Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Venous Thromboembolism
|
408 | 0.827 | 0.200 | 9 | 133279294 | upstream gene variant | T/G | snv | 0.81 | 0.800 | 1.000 | 2 | 2011 | 2012 | |||||
Coronary Artery Disease
|
1577 | 0.827 | 0.200 | 9 | 133279294 | upstream gene variant | T/G | snv | 0.81 | 0.710 | 1.000 | 2 | 2018 | 2019 | |||||
Hematocrit procedure
|
216 | 0.827 | 0.200 | 9 | 133279294 | upstream gene variant | T/G | snv | 0.81 | 0.700 | 1.000 | 2 | 2010 | 2017 | |||||
Hemoglobin measurement
|
224 | 0.827 | 0.200 | 9 | 133279294 | upstream gene variant | T/G | snv | 0.81 | 0.700 | 1.000 | 2 | 2010 | 2017 | |||||
Red Blood Cell Count measurement
|
1599 | 0.827 | 0.200 | 9 | 133279294 | upstream gene variant | T/G | snv | 0.81 | 0.700 | 1.000 | 2 | 2010 | 2017 | |||||
Alcohol consumption
|
535 | 0.827 | 0.200 | 9 | 133279294 | upstream gene variant | T/G | snv | 0.81 | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||
Alkaline phosphatase measurement
|
79 | 0.827 | 0.200 | 9 | 133279294 | upstream gene variant | T/G | snv | 0.81 | 0.700 | 1.000 | 1 | 2010 | 2010 | |||||
Blood Protein Measurement
|
2575 | 0.827 | 0.200 | 9 | 133279294 | upstream gene variant | T/G | snv | 0.81 | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||
C-reactive protein measurement
|
624 | 0.827 | 0.200 | 9 | 133279294 | upstream gene variant | T/G | snv | 0.81 | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||
Corpuscular Hemoglobin Concentration Mean
|
4389 | 0.827 | 0.200 | 9 | 133279294 | upstream gene variant | T/G | snv | 0.81 | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||
Diabetes Mellitus, Non-Insulin-Dependent
|
2672 | 0.827 | 0.200 | 9 | 133279294 | upstream gene variant | T/G | snv | 0.81 | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||
Eczema
|
368 | 0.827 | 0.200 | 9 | 133279294 | upstream gene variant | T/G | snv | 0.81 | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||
Low density lipoprotein cholesterol measurement
|
1142 | 0.827 | 0.200 | 9 | 133279294 | upstream gene variant | T/G | snv | 0.81 | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||
Protein measurement
|
422 | 0.827 | 0.200 | 9 | 133279294 | upstream gene variant | T/G | snv | 0.81 | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||
Serum albumin measurement
|
3282 | 0.827 | 0.200 | 9 | 133279294 | upstream gene variant | T/G | snv | 0.81 | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||
Triglycerides measurement
|
1418 | 0.827 | 0.200 | 9 | 133279294 | upstream gene variant | T/G | snv | 0.81 | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||
Venous Thrombosis
|
218 | 0.827 | 0.200 | 9 | 133279294 | upstream gene variant | T/G | snv | 0.81 | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||
von Willebrand's factor (lab test)
|
427 | 0.827 | 0.200 | 9 | 133279294 | upstream gene variant | T/G | snv | 0.81 | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||
Coughing
|
16 | 0.827 | 0.200 | 9 | 133279294 | upstream gene variant | T/G | snv | 0.81 | 0.020 | 1.000 | 2 | 2011 | 2014 | |||||
Essential Hypertension
|
293 | 0.827 | 0.200 | 9 | 133279294 | upstream gene variant | T/G | snv | 0.81 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Hypertensive disease
|
1085 | 0.827 | 0.200 | 9 | 133279294 | upstream gene variant | T/G | snv | 0.81 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Malignant Neoplasms
|
1641 | 0.827 | 0.200 | 9 | 133279294 | upstream gene variant | T/G | snv | 0.81 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Paroxysmal nocturnal hemoglobinuria
|
12 | 0.827 | 0.200 | 9 | 133279294 | upstream gene variant | T/G | snv | 0.81 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Primary malignant neoplasm
|
1374 | 0.827 | 0.200 | 9 | 133279294 | upstream gene variant | T/G | snv | 0.81 | 0.010 | 1.000 | 1 | 2014 | 2014 |